Daniel B. Rifkin

845 total citations
16 papers, 720 citations indexed

About

Daniel B. Rifkin is a scholar working on Molecular Biology, Hematology and Physiology. According to data from OpenAlex, Daniel B. Rifkin has authored 16 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Hematology and 4 papers in Physiology. Recurrent topics in Daniel B. Rifkin's work include Protease and Inhibitor Mechanisms (3 papers), Cell Adhesion Molecules Research (3 papers) and Protein Structure and Dynamics (2 papers). Daniel B. Rifkin is often cited by papers focused on Protease and Inhibitor Mechanisms (3 papers), Cell Adhesion Molecules Research (3 papers) and Protein Structure and Dynamics (2 papers). Daniel B. Rifkin collaborates with scholars based in United States, Argentina and United Kingdom. Daniel B. Rifkin's co-authors include Martha B. Furie, Richard W. Compans, E. Reich, Paolo Mignatti, Alan B. Frey, William H. Konigsberg, M R Rifkin, Hideoki Ogawa, Ryoji Tsuboi and J. P. Quigley and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Daniel B. Rifkin

16 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel B. Rifkin United States 13 267 200 169 108 106 16 720
D M Kazazis United States 10 247 0.9× 323 1.6× 119 0.7× 71 0.7× 243 2.3× 10 833
Kathryn Pyne United States 12 504 1.9× 373 1.9× 121 0.7× 146 1.4× 165 1.6× 12 1.1k
Kenneth J. Mandell United States 17 510 1.9× 243 1.2× 104 0.6× 105 1.0× 145 1.4× 27 1.1k
C. G. Smith United Kingdom 14 245 0.9× 73 0.4× 200 1.2× 121 1.1× 104 1.0× 18 647
Mario Piccoli Italy 26 432 1.6× 159 0.8× 101 0.6× 346 3.2× 126 1.2× 48 1.7k
Jui‐Lan Su United States 13 419 1.6× 99 0.5× 95 0.6× 125 1.2× 60 0.6× 21 842
M B Prystowsky United States 15 681 2.6× 141 0.7× 116 0.7× 334 3.1× 53 0.5× 28 1.7k
N. Kraft Australia 19 341 1.3× 123 0.6× 32 0.2× 105 1.0× 75 0.7× 48 1.0k
J E DeLarco United States 15 490 1.8× 70 0.3× 95 0.6× 160 1.5× 50 0.5× 19 897
Marika Christodoulou United Kingdom 4 422 1.6× 181 0.9× 460 2.7× 319 3.0× 39 0.4× 4 1.2k

Countries citing papers authored by Daniel B. Rifkin

Since Specialization
Citations

This map shows the geographic impact of Daniel B. Rifkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel B. Rifkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel B. Rifkin more than expected).

Fields of papers citing papers by Daniel B. Rifkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel B. Rifkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel B. Rifkin. The network helps show where Daniel B. Rifkin may publish in the future.

Co-authorship network of co-authors of Daniel B. Rifkin

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel B. Rifkin. A scholar is included among the top collaborators of Daniel B. Rifkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel B. Rifkin. Daniel B. Rifkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Recouvreux, M. Victoria, et al.. (2015). The pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomas. Journal of Endocrinology. 228(3). R73–R83. 40 indexed citations
2.
Habashi, Jennifer, Daniel P. Judge, Tammy M. Holm, et al.. (2006). Losartan in Marfan Syndrome—Beyond Blood Pressure Lowering. Journal of the American Society of Nephrology. 17(7). 1759–1764. 3 indexed citations
3.
Mignatti, Paolo & Daniel B. Rifkin. (1999). Nonenzymatic Interactions between Proteinases and the Cell Surface: Novel Roles in Normal and Malignant Cell Physiology. Advances in cancer research. 78. 103–157. 70 indexed citations
4.
Higgins, Rosemary D., et al.. (1998). Hyperoxia stimulates endothelin-1 secretion from endothelial cells; modulation by captopril and nifedipine. Current Eye Research. 17(5). 487–493. 29 indexed citations
5.
Tsuboi, Ryoji, et al.. (1992). A Wound Healing Model Using Healing‐impaired Diabetic Mice. The Journal of Dermatology. 19(11). 673–675. 61 indexed citations
6.
Levin, Richard I., et al.. (1984). Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity.. Journal of Clinical Investigation. 74(2). 571–580. 52 indexed citations
7.
Furie, Martha B. & Daniel B. Rifkin. (1980). Proteolytically derived fragments of human plasma fibronectin and their localization within the intact molecule.. Journal of Biological Chemistry. 255(7). 3134–3140. 127 indexed citations
8.
Furie, Martha B., Alan B. Frey, & Daniel B. Rifkin. (1980). Location of a gelatin-binding region of human plasma fibronectin.. Journal of Biological Chemistry. 255(10). 4391–4394. 67 indexed citations
9.
Griffin, B. E., Ulrike Novak, Nigel K. Spurr, et al.. (1980). Early Mutants of Polyoma Virus (dl8 and dl23) with Altered Transformation Properties: Is Polyoma Virus Middle T Antigen a Transforming Gene Product?. Cold Spring Harbor Symposia on Quantitative Biology. 44(0). 271–283. 38 indexed citations
10.
Rifkin, Daniel B., et al.. (1979). Fibronectin from chicken embryo fibroblasts contains covalently bound phosphate.. The Journal of Cell Biology. 80(3). 784–791. 25 indexed citations
11.
Eger, Richard & Daniel B. Rifkin. (1977). The preparation and use of pyridoxal [32P] phosphate as a labeling reagent for proteins on the outer surface of membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 470(1). 70–83. 13 indexed citations
12.
Rifkin, Daniel B. & J. P. Quigley. (1974). Virus-Induced Modification of Cellular Membranes Related to Viral Structure. Annual Review of Microbiology. 28(1). 325–352. 24 indexed citations
13.
Rifkin, Daniel B., Richard W. Compans, & E. Reich. (1972). A Specific Labeling Procedure for Proteins on the Outer Surface of Membranes. Journal of Biological Chemistry. 247(20). 6432–6437. 121 indexed citations
14.
Rifkin, Daniel B., M R Rifkin, & William H. Konigsberg. (1966). The presence of two major hemoglobin components in an inbred strain of mice.. Proceedings of the National Academy of Sciences. 55(3). 586–592. 34 indexed citations
15.
Rifkin, Daniel B., M R Rifkin, & William H. Konigsberg. (1966). Isolation and amino acid composition of the tryptic peptides from the beta chain of C57BL/6 mouse hemoglobin. Archives of Biochemistry and Biophysics. 116(1). 284–292. 6 indexed citations
16.
Rifkin, Daniel B., David Hirsh, M R Rifkin, & William H. Konigsberg. (1966). A Possible Ambiguity in the Coding of Mouse Hemoglobin. Cold Spring Harbor Symposia on Quantitative Biology. 31(0). 715–718. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026